|
Vaccine Detail
Herpes simplex virus DNA vaccine gD-2 encoding gD |
Vaccine Information |
- Vaccine Name: Herpes simplex virus DNA vaccine gD-2 encoding gD
- Target Pathogen: Herpes simplex virus type 1 and 2
- Target Disease: Herpes
- Vaccine Ontology ID: VO_0004365
- Type: DNA vaccine
- Status: Research
- Host Species as Laboratory Animal Model: Mouse, guinea pig
- gD
gene engineering:
- Type: DNA vaccine construction
- Description: Vector V1Jns expressed the HSV-2 gD gene (McClements et al., 1996).
- Detailed Gene Information: Click Here.
- DNA vaccine plasmid:
- DNA vaccine plasmid name:
- DNA vaccine plasmid VO ID: VO_0000328
- Immunization Route: Intraperitoneal injection (i.p.)
|
Host Response |
Mouse Response
- Vaccine Immune Response Type: VO_0000286
- Immune Response: The DNA immunization has the capacity to elicit cell-mediated, as well as humoral immune responses. In addition, injection of mice showed that each construction induced neutralizing serum antibodies (McClements et al., 1996).
- Efficacy: Immunized and control (saline-injected) mice were challenged by i.p. injection of HSV-2 and observed daily for survival. Significant protection from death (P< 0.001) was achieved for each dose. Eighty-two of eighty-six gD-2 DNA-immunized mice survived challenge (McClements et al., 1996).
|
References |
McClements et al., 1996: McClements WL, Armstrong ME, Keys RD, Liu MA. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proceedings of the National Academy of Sciences of the United States of America. 1996; 93(21); 11414-11420. [PubMed: 8876149].
|
|